Arif Atahan Çağatay
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 4
- Antifungal resistance and susceptibility 3
- HIV/AIDS Research and Interventions 2
- HIV/AIDS drug development and treatment 2
- Surgery 8
- Infectious Diseases and Tuberculosis 4
- Co-authors
- Haluk Eraksoy (10 shared papers)Patrice Nordmann (1 shared paper)Laurent Poirel (1 shared paper)Selim Badur (1 shared paper)Semra Çalangu (7 shared papers)Elif Kocasoy Orhan (1 shared paper)Mustafa Ertaş (1 shared paper)Hayrünnisa Bolay (1 shared paper)
- Journals
- Medical Mycology (2 papers)Clinical Microbiology and Infection (2 papers)Mycoses (1 paper)Journal of Aging Research (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)
- Partner nations
- TürkiyeSwedenUnited States
In The Last Decade
Arif Atahan Çağatay
29 papers receiving 540 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 193
- Applied Microbiology and Biotechnology 36
- Endocrinology 79
- Microbiology 7
- Infectious Diseases 109
Countries citing papers authored by Arif Atahan Çağatay
This map shows the geographic impact of Arif Atahan Çağatay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arif Atahan Çağatay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arif Atahan Çağatay more than expected).
Fields of papers citing papers by Arif Atahan Çağatay
This network shows the impact of papers produced by Arif Atahan Çağatay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arif Atahan Çağatay. The network helps show where Arif Atahan Çağatay may publish in the future.
Co-authors
The 25 scholars most cited alongside Arif Atahan Çağatay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 182 | |
| 2 | 2020 | 101 | |
| 3 | 2002 | 48 | |
| 4 | 2004 | 37 | |
| 5 | 2004 | 24 | |
| 6 | Risk factors for mortality in patients with nosocomial Gram-negative rod bacteremia. | 2013 | 21 |
| 7 | 2007 | 19 | |
| 8 | 2010 | 16 | |
| 9 | 2006 | 13 | |
| 10 | 2009 | 13 | |
| 11 | 2020 | 10 | |
| 12 | 2016 | 9 | |
| 13 | 2008 | 9 | |
| 14 | 2014 | 8 | |
| 15 | 2006 | 8 | |
| 16 | 2008 | 7 | |
| 17 | 2008 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2019 | 6 | |
| 20 | 2009 | 4 |
About Arif Atahan Çağatay
Arif Atahan Çağatay is a scholar working on Infectious Diseases, Surgery, Epidemiology, Oncology and Emergency Medicine, having authored 34 papers that have together received 566 indexed citations. Recurring topics across this work include Infectious Diseases and Tuberculosis (4 papers), COVID-19 Clinical Research Studies (4 papers), Antifungal resistance and susceptibility (3 papers), Antibiotic Resistance in Bacteria (3 papers), Bacterial Infections and Vaccines (2 papers), Pneumonia and Respiratory Infections (2 papers), HIV/AIDS Research and Interventions (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Molecular Medicine (193 citations), Applied Microbiology and Biotechnology (36 citations), Endocrinology (79 citations), Microbiology (7 citations) and Infectious Diseases (109 citations). Arif Atahan Çağatay has collaborated with scholars based in Türkiye, Sweden and United States. Frequent co-authors include Haluk Eraksoy, Patrice Nordmann, Laurent Poirel, Selim Badur, Semra Çalangu, Elif Kocasoy Orhan, Mustafa Ertaş, Hayrünnisa Bolay, Betül Baykan and Aynur Özge. Their work appears in journals such as Medical Mycology, Clinical Microbiology and Infection, Mycoses, Journal of Aging Research and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.